⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ATYR News
aTyr Pharma, Inc. Common Stock
Pomerantz LLP Shares Class Action Details With Investors in aTyr Pharma, Inc. – ATYR
accessnewswire.com
ATYR
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma
globenewswire.com
ATYR
ATYR DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages aTyr Pharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATYR
globenewswire.com
ATYR
ATYR Lawsuit: Hagens Berman Urges aTyr Pharma Investors to Act by Dec. 8 Deadline in Suit Over Trial Failure
prnewswire.com
ATYR
Securities Fraud Class Action Filed Against aTyr Pharma, Inc. (ATYR) - Levi & Korsinsky Reminds Investors of December 8, 2025
accessnewswire.com
ATYR
aTyr Pharma, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – ATYR
globenewswire.com
ATYR
ATYR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that aTyr Pharma, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
ATYR
Pomerantz LLP Reminds Shareholders: Securities Lawsuit Has Been Filed Against aTyr Pharma, Inc. – ATYR
accessnewswire.com
ATYR
ATYR Lawsuit: Hagens Berman Urges aTyr Pharma Investors to Act by Dec. 8 Deadline in Suit Over Trial Failure
globenewswire.com
ATYR
ATYR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that aTyr Pharma, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
globenewswire.com
ATYR